Published on Journal of Alzheimer's Disease (https://www.j-alz.com)

Home > Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-β concentrations and cognition outcomes in Alzheimer’s disease patients: a multicenter, randomized, controlled clinical trial

Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-β concentrations and cognition outcomes in Alzheimer’s disease patients: a multicenter, randomized, controlled clinical trial

Manuscript Number: 

16-0565R1

Author(s): 
Montserrat Alegret, Fernando Anaya, Mercè Boada, Mar Buendía, Isidre Ferrer, Joan Ramon Grifols, Isabel Hernández, Asunción Lafuente, Oscar Lopez, Joan Muñoz, Laura Núñez, Thomas O. Obisesan, Javier Olazarán, Pilar Ortiz, Antonio Páez, Joshua R. Shua-Haim, Mireia Torres, Lluís Tárraga
Source URL: https://www.j-alz.com/manuscript-disclosures/16-0565r1